Elevated BLyS levels in patients with systemic lupus erythematosus: Associated factors and responses to belimumab

INTRODUCTION: Patients with systemic lupus erythematosus (SLE) with B-lymphocyte stimulator (BLyS) levels ≥ 2 ng/mL are at increased risk of flare. A regression analysis was undertaken to identify routine clinical measures that correlate with BLyS ≥ 2 ng/mL. Efficacy and safety of belimumab 10 mg/kg...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Lupus
Päätekijät: Roth, D A, Thompson, A, Tang, Y, Hammer, A E, Molta, C T, Gordon, D
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: SAGE Publications 2015
Aiheet:
Papers
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4785993/
https://ncbi.nlm.nih.gov/pubmed/26385220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0961203315604909
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia